Division of Anaesthesiology, Intensive Care and Pain Medicine, Department of Anaesthesiology, Töölö Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
PLoS One. 2021 Jun 7;16(6):e0252626. doi: 10.1371/journal.pone.0252626. eCollection 2021.
Spinal fusion surgery causes severe pain. Strong opioids, commonly used as postoperative analgesics, may have unwanted side effects. S-ketamine may be an effective analgesic adjuvant in opioid patient-controlled analgesia (PCA). However, the optimal adjunct S-ketamine dose to reduce postoperative opioid consumption is still unknown.
We randomized 107 patients at two tertiary hospitals in a double-blinded, placebo-controlled clinical trial of adults undergoing major lumbar spinal fusion surgery. Patients were randomly allocated to four groups in order to compare the effects of three different doses of adjunct S-ketamine (0.25, 0.5, and 0.75 mg ml-1) or placebo on postoperative analgesia in oxycodone PCA. Study drugs were administered for 24 hours postoperative after which oxycodone-PCA was continued for further 48 hours. Our primary outcome was cumulative oxycodone consumption at 24 hours after surgery.
Of the 100 patients analyzed, patients receiving 0.75 mg ml-1 S-ketamine in oxycodone PCA needed 25% less oxycodone at 24 h postoperatively (61.2 mg) compared with patients receiving 0.5 mg ml-1 (74.7 mg) or 0.25 mg ml-1 (74.1 mg) S-ketamine in oxycodone or oxycodone alone (81.9 mg) (mean difference: -20.6 mg; 95% confidence interval [CI]: -41 to -0.20; P = 0.048). A beneficial effect in mean change of pain intensity at rest was seen in the group receiving 0.75 mg ml-1 S-ketamine in oxycodone PCA compared with patients receiving lower ketamine doses or oxycodone alone (standardized effect size: 0.17, 95% CI: 0.013-0.32, P = 0.033). The occurrence of adverse events was similar among the groups.
Oxycodone PCA containing S-ketamine as an adjunct at a ratio of 1: 0.75 decreased cumulative oxycodone consumption at 24 h after major lumbar spinal fusion surgery without additional adverse effects.
脊柱融合手术会引起严重疼痛。常用作术后镇痛的强阿片类药物可能会产生不良的副作用。S-氯胺酮可能是阿片类药物患者自控镇痛(PCA)的有效镇痛辅助药物。然而,减少术后阿片类药物消耗的最佳辅助 S-氯胺酮剂量仍不清楚。
我们在两家三级医院进行了一项双盲、安慰剂对照的成人大型腰椎脊柱融合手术临床试验,随机将 107 名患者分为四组,以比较三种不同剂量辅助 S-氯胺酮(0.25、0.5 和 0.75mg/ml)或安慰剂对术后阿片类药物 PCA 中术后镇痛的影响。术后 24 小时内给予研究药物,然后继续使用羟考酮 PCA 48 小时。我们的主要结局是术后 24 小时内累积羟考酮消耗量。
在 100 名接受分析的患者中,与接受 0.5mg/ml S-氯胺酮或 0.25mg/ml S-氯胺酮或单独羟考酮(81.9mg)的患者相比,接受 0.75mg/ml S-氯胺酮的患者在术后 24 小时内需要的羟考酮减少 25%(61.2mg)(平均差异:-20.6mg;95%置信区间[CI]:-41 至-0.20;P=0.048)。与接受较低剂量氯胺酮或单独羟考酮的患者相比,接受 0.75mg/ml S-氯胺酮与羟考酮 PCA 的患者在静息时疼痛强度的平均变化方面具有有益的效果(标准化效应量:0.17,95%CI:0.013-0.32,P=0.033)。各组不良反应的发生情况相似。
在主要腰椎脊柱融合手术后,含有 S-氯胺酮的羟考酮 PCA 以 1:0.75 的比例添加,可减少术后 24 小时内羟考酮的累积消耗量,且无额外的不良影响。